196 related articles for article (PubMed ID: 22240784)
1. The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma.
Dutta S; Going JJ; Crumley AB; Mohammed Z; Orange C; Edwards J; Fullarton GM; Horgan PG; McMillan DC
Br J Cancer; 2012 Feb; 106(4):702-10. PubMed ID: 22240784
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer.
Crumley AB; Going JJ; Hilmy M; Dutta S; Tannahill C; McKernan M; Edwards J; Stuart RC; McMillan DC
Ann Surg Oncol; 2011 Sep; 18(9):2604-12. PubMed ID: 21409484
[TBL] [Abstract][Full Text] [Related]
4. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
Noble F; Mellows T; McCormick Matthews LH; Bateman AC; Harris S; Underwood TJ; Byrne JP; Bailey IS; Sharland DM; Kelly JJ; Primrose JN; Sahota SS; Bateman AR; Thomas GJ; Ottensmeier CH
Cancer Immunol Immunother; 2016 Jun; 65(6):651-62. PubMed ID: 27020682
[TBL] [Abstract][Full Text] [Related]
5. High CD8
Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.
Murri AM; Hilmy M; Bell J; Wilson C; McNicol AM; Lannigan A; Doughty JC; McMillan DC
Br J Cancer; 2008 Oct; 99(7):1013-9. PubMed ID: 18797461
[TBL] [Abstract][Full Text] [Related]
7. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment.
O'Neill JR; Stephens NA; Save V; Kamel HM; Phillips HA; Driscoll PJ; Paterson-Brown S
Br J Surg; 2013 Jul; 100(8):1055-63. PubMed ID: 23616367
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus.
Knight WRC; McEwen R; Byrne BE; Habib W; Bott R; Zylstra J; Mahadeva U; Gossage JA;
Eur J Surg Oncol; 2020 Dec; 46(12):2257-2261. PubMed ID: 32814680
[TBL] [Abstract][Full Text] [Related]
9. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
[TBL] [Abstract][Full Text] [Related]
10. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.
Deans DA; Wigmore SJ; Gilmour H; Paterson-Brown S; Ross JA; Fearon KC
Br J Cancer; 2006 Dec; 95(11):1568-75. PubMed ID: 17088911
[TBL] [Abstract][Full Text] [Related]
11. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.
Crumley AB; McMillan DC; McKernan M; Going JJ; Shearer CJ; Stuart RC
Br J Cancer; 2006 Jun; 94(11):1568-71. PubMed ID: 16685271
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Jagadesham VP; Lagarde SM; Immanuel A; Griffin SM
Br J Surg; 2017 Mar; 104(4):401-407. PubMed ID: 28072456
[TBL] [Abstract][Full Text] [Related]
14. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
Ti TK
Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
[TBL] [Abstract][Full Text] [Related]
15. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
[TBL] [Abstract][Full Text] [Related]
19. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
